- SPANNR
- Posts
- Issue #45
Issue #45
Issue #45
April 6, 2023 | Issue #45
Good evening. Welcome back to another issue of Spannr.In this week's newsletter:👵 The luxury brand shaking up the longevity industry 💸 Tally Health nabs $10 million📚 Weeking reading material
Dior: A New & Legitimate Force in Longevity
Dior, the world-renowned luxury fashion house brand, has announced an initiative to delve into the science of aging, with a focus on developing innovative skincare products.And this is no ordinary beauty brand's anti-aging hype...Dior is taking a serious, geroscience-focused approach that is worth paying attention to.In our latest post, we explore Dior's new mission, its groundbreaking collaboration, and the profound implications for the future of longevity research.
Tally Health, which launched in late February and was co-founded by Dr. David Sinclair, announced a $10 million seed round led by Forerunner Ventures, with additional participation by L Catterton, which incubated and initially backed the company, plus G9 Ventures and Second Sight Ventures.
In addition, celebrities including John Legend, Chrissy Teigen, Pedro Pascal, Shonda Rhimes, Kevin Hart, Rich Roll, Whitney Cummings, and Zac Efron have individually invested in the company.
A mental model for aging therapeutics market readiness (Stanete)
Immortalism: The New Religion for Those Who Want to Escape Death (Countere)
New form of omega-3 could prevent visual decline with Alzheimer’s disease (ASBMB)
New nanoparticles deliver gene-editing tech directly into the lungs (New Atlas)
Boosting the body’s anti-viral immune response may eliminate aging cells (EurekAlert)
We’re inhaling, eating, and drinking toxic chemicals. Now we need to figure out how they’re affecting us (MIT Technology Review)
Putting out the fire on the gas stove debate (Peter Attia)
The Maximum Human Lifespan Will Rise Dramatically This Century, Researchers Say (Singularity Hub)
US health officials aim to ‘transform’ Alzheimer’s disease research with $300 million data platform (CNN Health)
Performance:
Latest Price: $100.437d-Return: 4.22%Market Cap: $10.29b
ABOUT SPANNR
We are dedicated to helping people understand the biggest business and health story of all time: the unprecedented transformation of society that will result from extending human healthspan and lifespan.
If you have any questions about Spannr or want to get to know us better,
– we'd love to hear from you. We appreciate your interest in what we are creating.